Literature DB >> 11702783

PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

E Formstecher1, J W Ramos, M Fauquet, D A Calderwood, J C Hsieh, B Canton, X T Nguyen, J V Barnier, J Camonis, M H Ginsberg, H Chneiweiss.   

Abstract

The ERK 1/2 MAP kinase pathway controls cell growth and survival and modulates integrin function. Here, we report that PEA-15, a protein variably expressed in multiple cell types, blocks ERK-dependent transcription and proliferation by binding ERKs and preventing their localization in the nucleus. PEA-15 contains a nuclear export sequence required for its capacity to anchor ERK in the cytoplasm. Genetic deletion of PEA-15 results in increased ERK nuclear localization with consequent increased cFos transcription and cell proliferation. Thus, PEA-15 can redirect the biological outcome of MAP kinase signaling by regulating the subcellular localization of ERK MAP kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702783     DOI: 10.1016/s1534-5807(01)00035-1

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  127 in total

1.  ERK2 enters the nucleus by a carrier-independent mechanism.

Authors:  Angelique W Whitehurst; Julie L Wilsbacher; Youngjai You; Kate Luby-Phelps; Mary Shannon Moore; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  The PEA-15 protein regulates autophagy via activation of JNK.

Authors:  Barbara C Böck; Katrin E Tagscherer; Anne Fassl; Anika Krämer; Ina Oehme; Hans-Walter Zentgraf; Martina Keith; Wilfried Roth
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

3.  Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.

Authors:  Yosuke Watanabe; Fumiyuki Yamasaki; Yoshinori Kajiwara; Taiichi Saito; Takeshi Nishimoto; Chandra Bartholomeusz; Naoto T Ueno; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

4.  MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.

Authors:  Chandra Bartholomeusz; Tetsuro Oishi; Hitomi Saso; Ugur Akar; Ping Liu; Kimie Kondo; Anna Kazansky; Savitri Krishnamurthy; Jangsoon Lee; Francisco J Esteva; Junzo Kigawa; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2011-12-05       Impact factor: 6.261

5.  Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action.

Authors:  Alessandra Trencia; Anna Perfetti; Angela Cassese; Giovanni Vigliotta; Claudia Miele; Francesco Oriente; Stefania Santopietro; Ferdinando Giacco; Gerolama Condorelli; Pietro Formisano; Francesco Beguinot
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

6.  C5a-induced gene expression in human umbilical vein endothelial cells.

Authors:  Eric A Albrecht; Arul M Chinnaiyan; Sooryanarayana Varambally; Chandan Kumar-Sinha; Terrence R Barrette; J Vidya Sarma; Peter A Ward
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

7.  The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Authors:  Sandra Pastorino; Hemamalini Renganathan; Maisel J Caliva; Erin L Filbert; John Opoku-Ansah; Florian J Sulzmaier; Joanna E Gawecka; Guy Werlen; Andrey S Shaw; Joe W Ramos
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

8.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

9.  Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.

Authors:  Christopher J Lord; Niall Quinn; Colm J Ryan
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

10.  Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli.

Authors:  Kin Man Suen; Chi-Chuan Lin; Roger George; Fernando A Melo; Eleanor R Biggs; Zamal Ahmed; Melanie N Drake; Swathi Arur; Stefan T Arold; John E Ladbury
Journal:  Nat Struct Mol Biol       Date:  2013-04-14       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.